Login / Signup
Philip Gilbo
Scopus Author ID
ORCID
Publication Activity (10 Years)
Years Active: 2019-2019
Publications (10 Years): 1
Top Topics
Mesenchymal Stem Cells
Top Venues
Nature medicine
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Jason A Carter
,
Philip Gilbo
,
Gurinder S Atwal
IMPRES does not reproducibly predict response to immune checkpoint blockade therapy in metastatic melanoma.
Nature medicine
25 (12) (2019)